On-Demand Webinar Archives

On-Demand Webinar

Navigating the Biotech Funding Crunch: How to Achieve Your Next Value Inflection

For the past two years, the biotech sector saw a surge of venture funding and…

CertaraAugust 30, 2022

On-Demand Webinar

Using Clinical Pharmacology & Pharmacometrics to Accelerate Cell Therapy Development: A Patient’s CAR-T Journey

Cell therapies aim to treat, prevent, or potentially cure diseases. They are a relatively new…

CertaraJuly 8, 2022

On-Demand Webinar

eCTD Submission Challenges

Industry standards are continually evolving, creating an environment of rapid change. With change comes challenges.…

CertaraJune 1, 2022

On-Demand Webinar

Learn how to shorten the drug discovery design-make-test-analyze cycle with D360

Researchers use D360 to query research data efficiently across different data sources and to create…

CertaraMay 25, 2022

On-Demand Webinar

Ask Me Anything: Career Opportunities in Regulatory & Medical Writing

Have you ever wondered what it would be like to be a Regulatory or Medical…

CertaraMay 12, 2022

On-Demand Webinar

Approaches to Address the Regulatory Requirements for System Qualification of the Simcyp Simulator

Physiologically-based pharmacokinetic (PBPK) modeling is being increasingly used in drug development to avoid unnecessary clinical…

CertaraMay 9, 2022

On-Demand Webinar

Smarter Clinical Document Automation for Transparency and Disclosure Requirements

Transparency and disclosure efforts are an integral part of medical writing for submissions. Sponsors receive…

CertaraApril 14, 2022

On-Demand Webinar

eChalk Talk: How Oncology Drug Developers Can Prepare for FDA’s Project Optimus

Historically, the dosing strategy for oncology drugs has focused on use of the maximum tolerated…

CertaraMarch 22, 2022

On-Demand Webinar

Improved Workflow and Expanded functionality of RsNLME v1.1

R Speaks NLME (RsNLME) is a collection of R packages and companion RShiny apps that…

CertaraJanuary 31, 2022

On-Demand Webinar

What Oncology Drug Developers Should Expect from the FDA’s Project Optimus

Historically, the dosing strategy for oncology drugs has focused on the maximum tolerated dose. This…

CertaraJanuary 13, 2022

On-Demand Webinar

Navigating the Biotech Funding Crunch: How to Achieve Your Next Value Inflection

Using Clinical Pharmacology & Pharmacometrics to Accelerate Cell Therapy Development: A Patient’s CAR-T Journey

eCTD Submission Challenges

Learn how to shorten the drug discovery design-make-test-analyze cycle with D360

Ask Me Anything: Career Opportunities in Regulatory & Medical Writing

Approaches to Address the Regulatory Requirements for System Qualification of the Simcyp Simulator

Smarter Clinical Document Automation for Transparency and Disclosure Requirements

eChalk Talk: How Oncology Drug Developers Can Prepare for FDA’s Project Optimus

Improved Workflow and Expanded functionality of RsNLME v1.1

What Oncology Drug Developers Should Expect from the FDA’s Project Optimus

Newsletter sign up

Quick links

Solutions

Contact